Siemens Healthineers AG (ADR)
General ticker "SMMNY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $122.0B (TTM average)
Siemens Healthineers AG (ADR) follows the US Stock Market performance with the rate: 18.6%.
Estimated limits based on current volatility of 0.9%: low 21.99$, high 22.38$
Factors to consider:
- Company pays dividends (annually): last record date 2026-02-09, amount 0.37$ (Y1.68%)
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [23.04$, 33.52$]
- 2026-09-30 to 2027-09-30 estimated range: [25.90$, 36.96$]
Financial Metrics affecting the SMMNY estimates:
- Positive: with PPE of 17.0 at the end of fiscal year the price was neutral
- Positive: 7.67 < Operating profit margin, % of 14.70
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 3.77
- Negative: 0.73 < Interest expense per share per price, % of 0.77
- Negative: Investing cash flow per share per price, % of -1.65 <= -0.63
- Negative: Operating cash flow per share per price, % of 5.60 <= 6.64
- Negative: negative Industry operating cash flow (median)
Short-term SMMNY quotes
Long-term SMMNY plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | €21,680.00MM | €22,363.00MM | €22,033.00MM |
| Operating Expenses | €19,240.00MM | €19,063.00MM | €18,795.00MM |
| Operating Income | €2,440.00MM | €3,300.00MM | €3,238.00MM |
| Non-Operating Income | €-512.00MM | €-777.00MM | €-549.00MM |
| Interest Expense | €296.00MM | €476.00MM | €400.60MM |
| R&D Expense | €1,866.00MM | €1,918.00MM | €1,846.00MM |
| Income(Loss) | €1,928.00MM | €2,523.00MM | €2,689.00MM |
| Taxes | €403.00MM | €564.00MM | €645.67MM |
| Profit(Loss)* | €1,509.00MM | €1,942.00MM | €2,021.00MM |
| Stockholders Equity | €18,081.00MM | €18,199.00MM | €21,197.00MM |
| Inventory | €4,294.00MM | €4,179.00MM | €4,086.00MM |
| Assets | €46,684.00MM | €46,055.00MM | €52,134.75MM |
| Operating Cash Flow | €1,809.00MM | €2,469.00MM | €2,906.00MM |
| Capital expenditure | €838.00MM | €696.00MM | €771.00MM |
| Investing Cash Flow | €-1,069.00MM | €-666.00MM | €-854.00MM |
| Financing Cash Flow | €-380.00MM | €-1,300.00MM | €-2,440.00MM |
| Earnings Per Share** | €0.67 | €0.87 | €0.90 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.